今年以来中安科已经1次登上龙虎榜，最近一次登上龙虎榜为8月6日，当日龙虎榜净买入-1161.65万 元；买入总计7409.20万元 ，占总成交额比15.28%；卖出总计8570.85万元 ，占总成交额比17.68%。 资料显示，中安科股份有限公司位于湖北省武汉市武昌区紫沙路203号华中小龟山金融文化公园5栋，成 立日期1991年12月31日，上市日期1990年12月19日，公司主营业务涉及安保系统集成、安保运营服务及 物联网产品制造。主营业务收入构成为：安保运营服务66.03%，智慧城市系统集成27.76%，安保智能 产品制造5.88%，租赁0.31%，其他0.02%。 11月6日，中安科盘中下跌2.08%，截至09:53，报3.76元/股，成交1.50亿元，换手率1.71%，总市值 108.15亿元。 资金流向方面，主力资金净流出1254.06万元，特大单买入124.72万元，占比0.83%，卖出595.42万元， 占比3.96%；大单买入1908.14万元，占比12.70%，卖出2691.49万元，占比17.92%。 中安科所属申万行业为：计算机-软件开发-垂直应用软件。所属概念板块包括：低价、一带一路、 ...

中安科成立于1991年12月31日，于1990年12月19日在上海证券交易所上市，注册地址和办公地址均位于湖 北省武汉市。该公司是国内安保行业的重要企业，专注于安保系统集成、运营服务及物联网产品制造，具 备一定的技术与服务优势。 中安科主营业务为安保系统集成、安保运营服务及物联网产品制造，所属申万行业为计算机-软件开发-垂 直应用软件，涉及智慧医疗、低价、国产软件核聚变、超导概念、核电等概念板块。 A股股东户数较上期增加0.56% 截至2025年9月30日，中安科A股股东户数为11.69万，较上期增加0.56%；户均持有流通A股数量为1.98 万，较上期减少0.33%。十大流通股东中，香港中央结算有限公司位居第七大流通股东，持股1393.36万 股，相比上期减少70.61万股。 图：中安科营收及增速 经营业绩：营收行业第十四，净利润行业第九 2025年三季度，中安科营业收入达23.65亿元，在行业102家公司中排名第14。行业第一名上海钢联营收为 573.18亿元，第二名德赛西威为223.37亿元，行业平均数为17.12亿元，中位数为4.19亿元。当期净利润为 1.98亿元，行业排名第9，行业第一名德赛西威净 ...

Core Viewpoint - The A-share market shows a mixed performance with the Shanghai Composite Index at 3966.25 points, slightly down by 0.52%, while a total trading volume of 1,158.735 billion yuan has been recorded, indicating active market participation [1]. Group 1: Market Performance - The Shanghai Composite Index is currently above the annual line, reflecting a stable market condition despite a minor decline [1]. - A total of 129 A-shares have surpassed the annual line today, indicating a positive trend for many stocks [1]. Group 2: Individual Stock Performance - Notable stocks with significant deviation rates above the annual line include: - Zhong An Ke (600654) with a deviation rate of 7.81% and a daily increase of 9.88% [1]. - Ba Fang Shares (603489) with a deviation rate of 7.55% and a daily increase of 9.99% [1]. - Zejing Pharmaceutical (688266) with a deviation rate of 6.52% and a daily increase of 9.76% [1]. - Stocks with smaller deviation rates that have just crossed the annual line include ST Xiangxue, Keli'er, and Nanda Environment, indicating a cautious recovery [1].

Financial Performance - The company's operating revenue for the third quarter reached ¥811,304,192.58, an increase of 11.50% compared to the same period last year[5] - The total profit for the period was ¥197,767,667.24, with a year-to-date profit of ¥214,015,450.26, reflecting a significant increase of 1,030.01% year-on-year[5] - The net profit attributable to shareholders was ¥195,043,244.56 for the quarter, with a year-to-date net profit of ¥197,558,610.85, showing a year-on-year increase of 1,748.16%[5] - The basic earnings per share for the quarter was ¥0.0692, with a diluted earnings per share of ¥0.0692, reflecting an increase of 1,741.55% year-to-date[6] - The weighted average return on equity increased to 14.84%, up 1,711.37 percentage points compared to the previous year[6] - The total profit from the beginning of the year to the reporting period reached 1,030.01 million, driven by significant growth in main business revenue and improved operational performance in both overseas security operations and domestic product manufacturing[11] - The basic earnings per share for the year-to-date period was 1,741.55, reflecting the company's efforts to expand market operations and enhance service quality[11] - The diluted earnings per share for the year-to-date period was 1,789.64, supported by increased net profits from overseas security operations and domestic manufacturing[11] - The weighted average return on net assets for the year-to-date period was 1,711.37, influenced by debt restructuring gains and reduced amortization expenses from the stock incentive plan[11] Assets and Liabilities - Total assets at the end of the quarter were ¥3,657,099,259.46, a decrease of 3.27% from the end of the previous year[6] - The equity attributable to shareholders increased to ¥1,726,948,811.71, representing a growth of 4.18% compared to the end of the previous year[6] - Total assets as of September 30, 2025, were ¥3,657,099,259.46, a decrease from ¥3,780,703,469.85 at the end of 2024, representing a decline of approximately 3.3%[19] - Total liabilities as of September 30, 2025, were ¥1,930,150,447.75, down from ¥2,123,050,068.78 at the end of 2024, indicating a reduction of about 9.1%[19] Cash Flow - The cash flow from operating activities for the current reporting period decreased due to cash payments made for temporary custody of clients' funds in overseas security operations[11] - Cash and cash equivalents as of September 30, 2025, were ¥559,196,036.47, down from ¥759,387,883.28 at the end of 2024, a decrease of approximately 26.3%[18] - Cash inflows from operating activities for the first three quarters of 2025 amount to CNY 2,645,523,177.17, compared to CNY 2,478,334,952.28 in 2024, showing an increase of approximately 6.75%[26] - The net cash flow from operating activities is negative at CNY -18,694,561.73, an improvement from CNY -129,343,903.63 in the same period last year[26] - The net cash flow from investing activities is CNY -84,814,003.23, compared to CNY -677,519.54 in the previous year, indicating increased investment outflows[27] - The net cash flow from financing activities is CNY -37,385,733.66, a decrease from CNY 76,540,962.13 in 2024, suggesting reduced financing activities[27] - The cash and cash equivalents at the end of the period stand at CNY 307,385,727.76, down from CNY 328,050,460.60 in the previous year[27] - The company received CNY 249,345,762.53 in cash from borrowings during the first three quarters of 2025, compared to CNY 8,425,821.17 in 2024, indicating increased reliance on debt financing[27] Non-Recurring Items - Non-recurring gains and losses for the period amounted to ¥198,490,836.43, with significant contributions from government subsidies and asset disposal gains[9] - The company recognized a one-time gain of ¥197,389,518.01 from debt restructuring activities during the reporting period[9] - The company received a VAT refund of ¥561,900.91 related to software products, which is closely tied to its normal business operations[10] - The net profit attributable to shareholders for the current reporting period increased due to a reduction in stock incentive plan amortization expenses compared to the previous year and an increase in debt restructuring gains from active debt resolution efforts[11] Shareholder Information - The top shareholder, Wuhan Rongjing Industrial Investment Co., Ltd., holds 432,800,000 shares, accounting for 15.04% of the total shares[14] - Shenzhen Zhongheng Huizhi Investment Co., Ltd. holds 316,310,464 shares, representing 10.99% of the total shares, with all shares frozen[14] Research and Development - Research and development expenses for the first three quarters of 2025 were ¥49,474,347.64, a decrease from ¥56,523,877.14 in 2024, reflecting a reduction of approximately 12.4%[23] Comprehensive Income - The total comprehensive income for the first three quarters of 2025 is CNY 205,597,334.59, up from CNY 14,098,448.59 in 2024, indicating strong growth[24]

Core Viewpoint - The announcement details the restrictions on the exercise period for stock options under the company's 2023 stock option and restricted stock incentive plan, specifically highlighting the upcoming limitation on exercising stock options during a specified period [1][2]. Summary by Sections Incentive Plan Details - The second exercise period for the stock options granted under the incentive plan is valid from April 17, 2025, to April 16, 2026, with the exercise days required to be trading days [1]. - The restriction on the exercise period is set from October 26, 2025, to October 30, 2025, during which all incentive objects will be restricted from exercising their stock options [1]. Compliance and Procedures - The company will apply to the Shanghai branch of China Securities Depository and Clearing Corporation Limited for the necessary procedures related to the restriction on exercising stock options in accordance with relevant regulations [1].

关于 2023 年股票期权与限制性股票激励计划 中安科股份有限公司 限制行权期间的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2、本次限制行权期为 2025 年 10 月 26 日至 2025 年 10 月 30 日，在此期间 股票期权（期权代码：1000000368）的全部激励对象将限制行权。 3、公司将按照有关规定及时向中国证券登记结算有限责任公司上海分公司 申请办理限制行权相关事宜。 证券代码：600654 证券简称：中安科 公告编号：2025-074 特此公告。 中安科股份有限公司 中安科股份有限公司（以下简称"公司"）根据《2023 年股票期权与限制 性股票激励计划》（以下简称"激励计划"）和中国证券登记结算有限责任公司 上海分公司关于股票期权自主行权的相关规定，结合公司 2025 年第三季度报告 的披露计划，现对公司《激励计划》处于自主行权期的股票期权自主行权时间进 行限制，具体情况如下： 1、公司《激励计划》授予股票期权第二个行权期有效日期为 2025 年 4 月 17 日至 2026 年 4 月 ...

证券代码：600654 证券简称：中安科 公告编号：2025-073 中安科股份有限公司 关于 2023 年股票期权与限制性股票激励计划部分限 制性股票回购注销的实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购注销原因：根据《上市公司股权激励管理办法》及中安科股份有限 公司（以下简称"公司"）《2023 年股票期权与限制性股票激励计划》（以 下简称"《激励计划》"）的有关规定，公司《激励计划》首次授予及预留 授予的激励对象中有 6 名激励对象因个人原因离职，不再具备激励资格，由 公司回购注销其已获授但尚未解除限售的限制性股票数量合计为 933,750 股。 本次注销股份的有关情况 | 回购股份数量（股） | 注销股份数量（股） | | 注销日期 | | | | --- | --- | --- | --- | --- | --- | | 年 月 933,750 | 933,750 | 2025 | 10 | 23 | 日 | 一、本次限制性股票回购注销的决策与信息披露 公司于 2023 年 4 月 ...

上海君澜律师事务所 关于 中安科股份有限公司 2023 年股票期权与限制性股票激励计划 回购注销部分限制性股票实施相关事项 之 法律意见书 二〇二五年十月 上海君澜律师事务所 法律意见书 上海君澜律师事务所 关于中安科股份有限公司 2023 年股票期权与限制性股票激励计划 回购注销部分限制性股票实施相关事项之 法律意见书 致：中安科股份有限公司 （三）本所仅就公司本次回购注销相关法律事项发表意见，而不对公司本次回购 注销所涉及的会计、审计等专业事项发表意见，本所及经办律师不具备对该等专业事 1 上海君澜律师事务所（以下简称"本所"）接受中安科股份有限公司（以下简称 "公司"或"中安科"）的委托，根据《中华人民共和国公司法》（以下简称"《公司 法》"）《上市公司股权激励管理办法》（以下简称"《管理办法》"）《中安科股份有限公 司 2023 年股票期权与限制性股票激励计划》（以下简称"《激励计划》"或"本次激励 计划"）的规定，就中安科回购注销本次激励计划部分限制性股票实施相关事项（以下 简称"本次回购注销"）出具本法律意见书。 对本法律意见书，本所律师声明如下： （一）本所律师依据《中华人民共和国证券法》《律师 ...

Core Points - The company has completed the execution of its restructuring plan as confirmed by the Wuhan Intermediate People's Court [1] - The company has compensated investors for losses amounting to 865.80 million yuan due to false statements [2] - The company has adjusted its debt claim list following the withdrawal of lawsuits with China Merchants Securities [2] Summary by Sections - **Restructuring Plan**: The restructuring plan of the company has been confirmed as executed by the court, marking a significant milestone in its recovery process [1] - **Investor Compensation**: The total compensation for investors due to false statements stands at 86.58 million yuan, indicating the financial impact of previous misstatements [2] - **Legal Developments**: The company and China Merchants Securities have mutually withdrawn their lawsuits, leading to adjustments in the debt claim list and a potential increase in non-operating profit for 2025 by approximately 19.71 million yuan [2]

证券代码：600654 证券简称：中安科 公告编号：2025-072 二〇二五年十月十一日 2022 年 12 月 23 日，中安科股份有限公司（以下简称"中安科"或"公司"） 在指定信息披露媒体发布了《关于重整计划执行完毕的公告》（公告编号： 2022-092），公司收到湖北省武汉市中级人民法院送达的【（2022）鄂 01 破 26 号之二】《民事裁定书》，裁定确认《中安科股份有限公司重整计划》（以下简 称"《重整计划》"）执行完毕。 目前，公司已赔偿虚假陈述案件投资者损失共计 86,579.51 万元。公司于 2025 年 9 月 23 日在指定信息披露媒体发布了《关于诉讼进展的公告》（公告编号： 2025-069），公司和招商证券股份有限公司经双方协商互相撤回起诉。2025 年 9 月 30 日，公司收到中安科股份有限公司管理人的通知，结合前述情况对债权申 报列表进行了调整。根据企业会计准则的规定，公司在虚假陈述案件中针对投资 者预提的 3,014.24 万元现金和 5,858.79 万股股票偿债资源将予以转回，预计将 增加公司 2025 年年度非经常性利润 19,711.79 万元（具体会计处理以及对 ...